Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Stock Has Consensus Price Target of $11.33
Shares of Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Get Free Report) have been assigned an average recommendation of “Buy” from the nine ratings firms that are covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating, five have issued a buy rating and three have given a strong buy rating to […]
3 Oct 01:58 · The Cerbat Gem